Evidence map›Paper›PMID 40514597›Full record

ArticleEuropean radiology2025

Long-term prognostic value of the CT-derived fractional flow reserve combined with atherosclerotic burden in patients with non-obstructive coronary artery disease.

Zhiqiang Wang, Zhennan Li, Tingfeng Xu, Minxian Wang, Lei Xu, Yong Zeng

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhiqiang Wang *Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhennan Li *Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tingfeng Xu *CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China.
Minxian WangCAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China.
Lei XuDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. leixu2001@hotmail.com.
Yong ZengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. yzeng_anzhen@163.com.ORCID http://orcid.org/0000-0001-6983-0799

Funding

Beijing Municipal Health Bureau YGLX202324Beijing Municipal Science and Technology Commission Z211100003521022Chinese Society of Cardiology CSC2023A03Postdoctoral Fellowship Program of CPSF GZC20241098
6 · The paper itself

Abstract

objectivesThe long-term prognostic significance of the coronary computed tomography angiography (CCTA)-derived fractional flow reserve (CT-FFR) for non-obstructive coronary artery disease (CAD) is uncertain. We aimed to investigate the additional prognostic value of CT-FFR beyond CCTA-defined atherosclerotic burden for long-term outcomes. MATERIALS AND

methodsConsecutive patients with suspected stable CAD were candidates for this retrospective cohort study. Deep-learning-based vessel-specific CT-FFR was calculated. All patients enrolled were followed for at least 5 years. The primary outcome was major adverse cardiovascular events (MACE). Predictive abilities for MACE were compared among three models (model 1, constructed using clinical variables; model 2, model 1 + CCTA-derived atherosclerotic burden (Leiden risk score and segment involvement score); and model 3, model 2 + CT-FFR).

resultsA total of 1944 patients (median age, 59 (53-65) years; 53.0% men) were included. During a median follow-up time of 73.4 (71.2-79.7) months, 64 patients (3.3%) experienced MACE. In multivariate-adjusted Cox models, CT-FFR ≤ 0.80 (HR: 7.18; 95% CI: 4.25-12.12; p < 0.001) was a robust and independent predictor for MACE. The discriminant ability was higher in model 2 than in model 1 (C-index, 0.76 vs. 0.68; p = 0.001) and was further promoted by adding CT-FFR to model 3 (C-index, 0.83 vs. 0.76; p < 0.001). Integrated discrimination improvement (IDI) was 0.033 (p = 0.022) for model 2 beyond model 1. Of note, compared with model 2, model 3 also exhibited improved discrimination (IDI = 0.056; p < 0.001).

conclusionsIn patients with non-obstructive CAD, CT-FFR provides robust and incremental prognostic information for predicting long-term outcomes. The combined model including CT-FFR and CCTA-defined atherosclerotic burden exhibits improved prediction abilities, which is helpful for risk stratification. KEY POINTS: Question Prognostic significance of the CT-fractional flow reserve (FFR) in non-obstructive coronary artery disease for long-term outcomes merits further investigation. Findings Our data strongly emphasized the independent and additional predictive value of CT-FFR beyond coronary CTA-defined atherosclerotic burden and clinical risk factors. Clinical relevance The new combined predictive model incorporating CT-FFR can be satisfactorily used for risk stratification of patients with non-obstructive coronary artery disease by identifying those who are truly suitable for subsequent high-intensity preventative therapies and extensive follow-up for prognostic reasons.

Indexed as

Computed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseFractional Flow Reserve, MyocardialAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesComputed tomography angiographyCoronary artery diseaseFractional flow reserveNon-obstructivePrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.